Heterogeneity in breast cancer (BC) subtypes within a tumor contributes to therapy resistance and cancer recurrence. Development of subtype heterogeneity results from stochastic transitions between cell types as the tumor evolves over time. Here, we sought to characterize how NF-κB contributes to the progression of the human epidermal growth factor receptor 2-positive (HER2 + ) breast cancer subtype. Initially, we used RNA to determine the expression levels of NF-κB, TWIST1, SIP1, and SLUG in two breast cancer (BC) cell lines, HCC-1954 and MDA-MB-231, classified as HER2 + and triple-negative breast cancer (TNBC) subtypes, respectively. Then, we built and calibrated a Gene Regulatory Network (GRN) model reproducing the transcriptional regulation between these genes. For validation, we used DHMEQ-treated cells, along with published patient data and in vitro results. The model epigenetic landscape exhibits two attractor basins corresponding to both HER2 + and TNBC subtypes, separated by an unstable stationary state. Stochastic fluctuations in the NF-κB levels induce spontaneous irreversible transition from HER2 + to TNBC attractor basins at different times, contributing to subtype heterogeneity. The unstable state mediates this transition by providing a slow route between subtypes in the phase space that is susceptible to dynamic fluctuations. Mutations or drugs that change the availability of NF-κB alters the size of the subtype basins, changing the transition probabilities. Together, our findings enhance the established attractor landscape formulation and deepen understanding of BC heterogeneity, leading to more precise classification, prognosis, and targeted strategies for BC progression.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: